|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenues | |||||
| Net earned premiums | |||||
| Net investment income | |||||
| Net investment losses | |||||
| Non-insurance warranty revenue | |||||
| Other revenues | |||||
| Total revenues | |||||
| Claims, Benefits and Expenses | |||||
| Insurance claims and policyholders’ benefits (re-measurement loss of $104, $125 and $88) | |||||
| Amortization of deferred acquisition costs | |||||
| Non-insurance warranty expense | |||||
| Other operating expenses | |||||
| Interest | |||||
| Total claims, benefits and expenses | |||||
| Income before income tax | |||||
| Income tax expense | |||||
| Net income | |||||
| Basic earnings per share | |||||
| Basic earnings per share (in usd per share) | |||||
| Diluted earnings per share | |||||
| Diluted earnings per share (in usd per share) | |||||
| Weighted Average Outstanding Common Stock and Common Stock Equivalents | |||||
| Basic (in shares) | |||||
| Diluted (in shares) |
Loading...